eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2012
vol. 16
 
Share:
Share:
abstract:
Review paper

Endoglin – a marker of vascular endothelial cell proliferation in cancer

Ewa Kopczyńska
,
Roman Makarewicz

Wspolczesna Onkol 2012; 16 (1): 68–71
Online publish date: 2012/02/29
View full text Get citation
 
PlumX metrics:
Endoglin (CD105) is an accessory receptor of transforming growth factor B. The highest synthesis, as well as expression, of endoglin has been found in vascular endothelial cells. The involvement of endoglin in angiogenesis and in angiogenesis-dependent processes has been observed. Endoglin promotes angiogenesis not only by activation of vascular endothelial cell proliferation but also by induction of the antiapoptotic pathway in hypoxic endothelial cells. The potential application of endoglin as a tumour angiogenesis marker, useful for cancer diagnostics and clinical application, is anticipated. Endoglin expression may be useful as an indicator of disease progression and helpful for estimation of recurrence and metastasis risk.
keywords:

endoglin (CD105), vascular endothelial cells, tumor angiogenesis

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.